Skip to main content
. Author manuscript; available in PMC: 2015 Sep 11.
Published in final edited form as: Semin Immunol. 2014 May 28;26(5):369–379. doi: 10.1016/j.smim.2014.04.002

Table 1.

CB1 and CB2 agonist properties of cannabinoids

Cannabinoids CB1 CB2 Type Cannabinoid
Group
THC Partial agonist Partial agonist natural Classical
HU-210 Full agonist Full agonist synthetic Classical
CP-55940 Full agonist Full agonist synthetic Non-classical
R-(+)-WIN55,212–2 Full agonist Full agonist natural Aminoalkylindole
AEA Partial agonist Partial agonist natural Eicosanoid
2-AG Full agonist Full agonist natural Eicosanoid
R(+)-methanandamide Partial agonist Partial agonist synthetic Eicosanoid
ACEA Partial agonist Partial agonist synthetic Eicosanoid
HU-308 Weak CB1 binding Selective agonist synthetic Non-classical
JWH-133 Weak CB1 binding Selective agonist synthetic Classical
JWH-015 Weak CB1 binding Selective agonist synthetic Aminoalkylindole
AM124 Weak CB1 binding Selective agonist synthetic Aminoalkylindole
HHS Vulnerability Disclosure